Show simple item record

dc.contributor.authorBaarsma, M E
dc.contributor.authorSchellekens, Jfp
dc.contributor.authorMeijer, B C
dc.contributor.authorBrandenburg, A H
dc.contributor.authorSouilljee, T
dc.contributor.authorHofhuis, A
dc.contributor.authorHovius, J W
dc.contributor.authorvan Dam, A P
dc.date.accessioned2020-07-17T08:44:34Z
dc.date.available2020-07-17T08:44:34Z
dc.date.issued2020-07-06
dc.identifier.issn1435-4373
dc.identifier.pmid32632699
dc.identifier.doi10.1007/s10096-020-03946-0
dc.identifier.urihttp://hdl.handle.net/10029/623974
dc.language.isoenen_US
dc.subjectBorreliosisen_US
dc.subjectC6en_US
dc.subjectLyme diseaseen_US
dc.subjectModified two-tier testingen_US
dc.subjectSerologyen_US
dc.titleDiagnostic parameters of modified two-tier testing in European patients with early Lyme disease.en_US
dc.typeArticleen_US
dc.identifier.journalEur J Clin Microbiol Infect Dis 2020; 39(11):2143-52en_US
dc.source.journaltitleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology


This item appears in the following Collection(s)

Show simple item record